Treatment of patients with newly diagnosed standard risk B-precursor acute lymphoblastic leukemia (ALL)

eagle-i ID

Resource Type

Properties

1. ClinicalTrials.gov url

   http://www.clinicaltrial.gov/ct2/show/NCT01190930?term=NCT01190930&rank=1

2. Intervention

   Antineoplastic combined chemotherapy

3. Resource Description

   This partially randomized phase III clinical trial is studying different combinations of risk-adapted chemotherapy regimens and their side effects and comparing how well they work in treating younger patients with newly diagnosed standard-risk acute lymphoblastic leukemia.

4. Contact

   Berenberg, Jeffrey

5. PI

   Wilkinson, Robert, M.D.

6. Topic

   precursor B lymphoblastic lymphoma/leukemia

7. Study Population

   Children 1 to 9 years newly diagnosed with B-precursor acute lymphoblastic leukemia (ALL), and meeting other therapy-related criteria.

8. Phase

   Phase 3 clinical trial

9. Performed by

   Clinical Protocol & Data Management Shared Resource